Zhiguang Chen

Dr. Zhiguang Chen


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Theranostics
Verified
Journal Article
Open access
PDF file
ZCZhiguang Chen
Zhiguang Chen
WZWei Zhang
Wei Zhang
XQXiujuan Qu
Xiujuan Qu
YZYunfei Zhang
Yunfei Zhang
Piezoelectric heterojunctions are emerging as a transformative class of smart biomaterials, revolutionizing biomedical applications through their unique mechano-electrical coupling effects. A central challenge hindering their full potential lies in the systematic understanding and utilization of their complex interfacial enhancement mechanisms. This review aims to establish a comprehensive framework that bridges fundamental principles to clinical translation. We begin with an in-depth analysis of the core enhancement mechanisms in piezoelectric heterojunctions, focusing on the synergistic interplay between the built-in electric field and band engineering that promotes efficient charge separation. We then provide a critical discussion of the ongoing debate surrounding their catalytic mechanism, reconciling the distinctions and connections between band theory and the surface screening charge model. Furthermore, we construct a multidimensional classification system centered on material dimensionality and composition to offer systematic guidance for the rational design and performance optimization of piezoelectric heterojunctions. In terms of applications, this review offers a comprehensive survey of the cutting-edge progress of piezoelectric heterojunctions in efficient cancer therapy, tissue regeneration, antibacterial strategies, and self-powered biosensing. We emphasize that the superiority of these heterojunctions stems from their ability to overcome the bottlenecks of low efficiency and mono-functionality inherent in single-component piezoelectric materials through sophisticated interface design, while also maximizing therapeutic outcomes via multimodal synergistic strategies. Finally, we critically analyze the formidable challenges this field faces concerning biosafety, scalable fabrication, and clinical translation, and offer perspectives on its future development toward intelligent theranostic systems. This review is intended to provide solid theoretical guidance and forward-looking insights for the design of next-generation, high-performance piezoelectric biomaterials.

9 May 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
DBDonglin Bian
Donglin Bian
YLYanjun Liu
Yanjun Liu
ZBZhiqun Bai
Zhiqun Bai
Over the past decade, immunotherapy has revolutionized the clinical management of numerous cancer types. However, only a subset of patients derives long-term durable tumor control from it. Intriguingly, several emerging therapeutic strategies harnessing reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) hold promise for enabling precision immunotherapy in cancer, with sonodynamic therapy emerging as a notable example. The utilization of piezoelectric materials as sonosensitizers can effectively enhance ROS production, thereby augmenting the efficacy of ICD-induced immunotherapy. Additionally, electrical stimulation generated by the piezoelectric effect can further induce immune response activation and necroptosis, achieving a synergistic effect in piezo-catalytic immunotherapy. Herein, we will systematically review the pathways and potential mechanisms underlying piezo-catalytic immunotherapy, offering novel insights for the exploration of cancer immunotherapy strategies.

30 March 2026 in Theranostics
Verified
Journal Article
Open access
PDF file
SLSinong Li
Sinong Li
ZYZiyi Yang
Ziyi Yang
YZYing Zhang
Ying Zhang
GZGenyuan Zhang
Genyuan Zhang
ZCZoujuan Cai
Zoujuan Cai
LSLiang Sang
Liang Sang
Sonodynamic therapy (SDT), a tumor treatment modality characterized by deep tissue penetration and high spatiotemporal precision, faces multiple challenges in clinical translation, including suboptimal sonosensitizer efficiency, suppression by the tumor microenvironment (TME), and insufficient induction of antitumor immune responses. This paper systematically reviews the multifaceted sensitization strategies of SDT, breaking away from traditional single-optimization approaches to establish a comprehensive synergistic enhancement framework spanning the entire chain involving “material design-microenvironment regulation-immune remodeling-synergistic therapy.” In sonosensitizer engineering, current research emphasizes advanced design strategies—including defect engineering, heterostructure construction, and piezoelectric materials—to markedly enhance reactive oxygen species (ROS) generation through band structure modulation and mechano-electro-chemical coupling effects. To overcome the TME-associated constraints, a series of innovative strategies such as hypoxia alleviation, antioxidant depletion, metabolic reprogramming and bacteria-mediated targeted delivery have been developed to mitigate ROS scavenging and improve tumor selectivity. Furthermore, this review summarizes how SDT is integrated with multiple synergistic modalities such as chemodynamic therapy, phototherapy, immunotherapy, and ferroptosis/cuproptosis induction and systematically elucidates the underlying mechanisms and therapeutic potential of these combinations in triggering immunogenic cell death, reversing tumor immunosuppression, and ultimately enabling diagnostic-therapeutic integration. Despite persistent challenges in nanodelivery, controllable ROS generation, and clinical standardization, this review highlights that the development of multimodal, responsive, and biohybrid platforms is driving SDT toward a new paradigm of precise and intelligent cancer treatment. Collectively, these findings provide a systematic strategic blueprint with translational potential for treating deep-seated and drug-resistant solid tumors.